Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-27 Sale |
2023-03-29 5:12 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,000 | $14.72 | $29,435 | 255,811 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 4:37 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
1,747 | $10.53 | $18,389 | 85,157 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 4:32 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
1,641 | $10.56 | $17,336 | 84,330 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 4:36 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,000 | $12 | $24,000 | 161,835 (Direct) |
View |
| 2023-01-27 Sale |
2023-01-30 4:32 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,000 | $12 | $24,001 | 163,835 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-10 4:40 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,410 | $15.02 | $36,196 | 165,835 (Direct) |
View |
| 2022-12-30 Sale |
2023-01-03 4:32 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
5,200 | $13.45 | $69,932 | 15,516 (Direct) |
View |
| 2022-12-27 Sale |
2022-12-29 4:51 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
14,590 | $15.02 | $219,119 | 168,245 (Direct) |
View |
| 2022-12-08 Sale |
2022-12-12 4:36 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
4,550 | $18.95 | $86,238 | 117,456 (Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 5:02 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
3,110 | $18.19 | $56,559 | 227,703 (Direct) |
View |
| 2022-11-28 Sale |
2022-11-30 4:31 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,000 | $13.91 | $27,826 | 182,835 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 4:59 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
200 | $18.1 | $3,620 | 125,116 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-02 4:54 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
2,100 | $24.05 | $50,495 | 45,283 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:49 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
13,000 | $21.27 | $276,549 | 255,120 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:48 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
9,348 | $20.77 | $194,191 | 47,383 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:46 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
14,061 | $20.8 | $292,512 | 184,835 (Direct) |
View |
| 2022-10-20 Sale |
2022-10-24 5:13 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
6,080 | $18.66 | $113,426 | 56,731 (Direct) |
View |
| 2022-10-20 Sale |
2022-10-24 5:10 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
5,939 | $18.64 | $110,713 | 198,896 (Direct) |
View |
| 2022-09-26 Sale |
2022-09-28 5:12 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
10,587 | $15.25 | $161,442 | 204,835 (Direct) |
View |
| 2022-09-26 Sale |
2022-09-28 5:10 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
8,593 | $15.29 | $131,428 | 77,459 (Direct) |
View |
| 2022-09-26 Sale |
2022-09-28 5:08 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
1,544 | $15.45 | $23,854 | 62,811 (Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 4:59 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
4,425 | $15.1 | $66,838 | 215,422 (Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 4:57 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
4,280 | $15.08 | $64,560 | 70,905 (Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 4:55 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
4,293 | $15.11 | $64,878 | 64,355 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-19 4:35 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
200 | $15.04 | $3,008 | 219,847 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-19 4:34 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
100 | $15.01 | $1,501 | 68,648 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-19 4:32 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
106 | $15.01 | $1,591 | 49,621 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 4:21 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
1,788 | $15.12 | $27,039 | 220,047 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 4:18 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
2,021 | $15.11 | $30,531 | 79,538 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 4:14 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
1,777 | $15.11 | $26,845 | 68,748 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-01 Option Award(A) |
2023-04-19 5:49 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
35,700 | $0 | 49,457 (Direct) |
View |
| 2023-03-01 Option Award(A) |
2023-04-19 5:48 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
35,700 | $0 | 48,630 (Direct) |
View |
| 2023-03-01 Option Award(A) |
2023-04-19 5:46 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
35,700 | $0 | 79,955 (Direct) |
View |
| 2023-04-04 Option Award |
2023-04-04 5:17 pm |
N/A 2033-04-04 |
Entrada Therapeutics Inc. | TRDA | Zeiher Bernhardt G Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2023-03-02 Tax Withholding |
2023-03-03 4:37 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
1,005 | $11.6 | 85,157 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:37 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
71,400 | $0 | 85,157 (Direct) |
View |
| 2023-03-02 Tax Withholding |
2023-03-03 4:36 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
1,058 | $11.6 | 232,486 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:36 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
71,400 | $0 | 232,486 (Direct) |
View |
| 2023-03-02 Tax Withholding |
2023-03-03 4:34 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
3,324 | $11.6 | 408,311 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:34 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
249,800 | $0 | 408,311 (Direct) |
View |
| 2023-03-02 Tax Withholding |
2023-03-03 4:33 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
1,028 | $11.6 | 115,655 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:33 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
71,400 | $0 | 115,655 (Direct) |
View |
| 2023-03-02 Tax Withholding |
2023-03-03 4:32 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
945 | $11.6 | 84,330 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:32 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
71,400 | $0 | 84,330 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-12 4:36 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
4,550 | $2.1 | 117,456 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-12 4:36 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
4,550 | $0 | 117,456 (Direct) |
View |
| 2022-12-02 Exercise |
2022-12-06 5:02 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
3,110 | $2.1 | 227,703 (Direct) |
View |
| 2022-12-02 Exercise |
2022-12-06 5:02 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
3,110 | $0 | 227,703 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-18 4:59 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
200 | $2.1 | 125,116 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-18 4:59 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
200 | $0 | 125,116 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 6:49 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
13,000 | $2.1 | 255,120 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 6:49 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
13,000 | $0 | 255,120 (Direct) |
View |
| 2022-09-26 Exercise |
2022-09-28 5:10 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
8,593 | $2.1 | 77,459 (Direct) |
View |
| 2022-09-26 Exercise |
2022-09-28 5:10 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
8,593 | $0 | 77,459 (Direct) |
View |
| 2022-09-21 Exercise |
2022-09-23 4:57 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
4,280 | $2.1 | 70,905 (Direct) |
View |
| 2022-09-21 Exercise |
2022-09-23 4:57 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
4,280 | $0 | 70,905 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-19 4:32 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
106 | $2.1 | 49,621 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-19 4:32 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
106 | $0 | 49,621 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 4:18 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
2,021 | $2.1 | 79,538 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 4:18 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
2,021 | $0 | 79,538 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:34 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
5,503 | $0 | 16,489 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:33 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
5,794 | $0 | 162,144 (Direct) |
View |